View by Specialty

Trending

Anthony A. Romeo
November 15, 2024
4 min read
Save

Capitalism is the path to value-based care

Liver/Biliary Disorders News

SPONSORED CONTENT
Save
SPONSORED CONTENT
May 14, 2022
1 min read
Save

Hepatitis C incidence low among gay and bisexual men on PrEP, study finds

Hepatitis C incidence low among gay and bisexual men on PrEP, study finds

There were few incident hepatitis C virus infections recorded among gay and bisexual men participating in an HIV PrEP rollout study in Australia, researchers reported.

SPONSORED CONTENT
May 13, 2022
2 min read
Save

Liver fat percentage does not alter risk for CV events

Liver fat percentage does not alter risk for CV events

SAN DIEGO — Liver fat content is not associated with risk for any cardiovascular event, according to data from the Dallas Heart Study presented at the AACE Annual Scientific and Clinical Conference.

Trending

Anthony A. Romeo
November 15, 2024
4 min read
Save

Capitalism is the path to value-based care

SPONSORED CONTENT
May 13, 2022
2 min read
Save

Sex hormone-binding globulin level may predict liver fibrosis for men with NAFLD

Sex hormone-binding globulin level may predict liver fibrosis for men with NAFLD

SAN DIEGO — Higher sex hormone-binding globulin levels may predict liver fibrosis for men with nonalcoholic fatty liver disease, according to a presenter at the AACE Annual Scientific and Clinical Conference.

SPONSORED CONTENT
May 13, 2022
1 min read
Save

Cardiovascular disease more prevalent in lean vs. overweight, obese patients with NAFLD

Cardiovascular disease more prevalent in lean vs. overweight, obese patients with NAFLD

Lean patients with nonalcoholic fatty liver disease were at greater risk for cardiovascular and chronic kidney disease compared with overweight or obese patients, according to a researcher at the Digestive Disease Week 2022 media briefing.

SPONSORED CONTENT
May 12, 2022
2 min read
Save

Rapid treatment significantly increases HCV cure rate among injection drug users

Rapid treatment significantly increases HCV cure rate among injection drug users

A rapid treatment model that included a 7-day starter pack of medication significantly increased hepatitis C cure rates among young people who inject drugs, according to a small study.

SPONSORED CONTENT
May 11, 2022
1 min read
Save

Fatigue in patients with advanced NASH may increase risk for adverse events

Fatigue in patients with advanced NASH may increase risk for adverse events

Worse fatigue at baseline among patients with nonalcohol steatohepatitis-related advanced fibrosis and cirrhosis correlated with a higher risk adverse clinical events, according to published results.

SPONSORED CONTENT
May 10, 2022
1 min read
Save

Fibrotic NASH score may help health care providers predict at-risk patients

A noninvasive scoring system using routine laboratory data may help primary care providers screen for fibrotic nonalcoholic steatohepatitis and dysmetabolism in high-risk patients, according to a published study.

SPONSORED CONTENT
May 09, 2022
12 min watch
Save

VIDEO: Although acute hepatitis in children uncommon, parents should remain vigilant

VIDEO: Although acute hepatitis in children uncommon, parents should remain vigilant

In this Healio video exclusive, Elizabeth Fagan, MD, an independent hepatologist and consultant in Texas, discusses global concerns about cases of acute, severe hepatitis in children and what caregivers should be aware of.

SPONSORED CONTENT
May 06, 2022
3 min read
Save

CDC: Investigation ongoing, need time to evaluate evidence for acute hepatitis in children

CDC: Investigation ongoing, need time to evaluate evidence for acute hepatitis in children

The CDC reported during a media telebriefing that it is investigating cases of acute hepatitis of unknown etiology among children in the United States but warns it will take time to evaluate evidence.

SPONSORED CONTENT
May 03, 2022
1 min read
Save

PPI use should be limited to appropriate indications, lowest effective dose in cirrhosis

PPI use should be limited to appropriate indications, lowest effective dose in cirrhosis

Although proton pump inhibitors were linked with an increased risk for infection and decompensation in patients with cirrhosis, they may still be of benefit in those with prior gastrointestinal bleeding, according to published data.

View more